Content Blocks

We can do a up to 4 columns in a section.

We can set columns widths to different percentages. This section starts wityh a 40% width, followed by 3 at 20%, which is the minimum percentage allowed.

We can add divider arrows to sections to visually lead to the next.

See below for transition from white to grey.

Accordion Content

Sharing Content Part

Random Stats

Text before number

$5,000

Number Description

If you see these first, than refresh to see the other set of stats!

Before

50%

This one is displayed horizontal

These can change every time you visit. Try refreshing the page.

You refeshed!

2nd

set of stats

wow

2

sets of stats

and we can add even more sets!

On the left is a “guideline”.

As you scroll down, it animates to give a visual lead to the next section.

Use it if you want to lead the user down the page past the “fold line”

And then give it an “end point”

Randomized Testimonials

We can add several quotes, and a new one will show up each time the user visits the site.

John Fernhout

Impact Stats

This content block type is to show the impact your organization has had in the communtiy

more than

5,000

medical visits

added through expansion

over

14K

pounds of trash

cleaned from 70+ miles of shorelines

2,000+

students

participated in our programs

Our Impact

more than

6,000

Albertans

have taken part in 500 trials

4,400

patients

in rural Alberta will access their local Alberta Cancer Foundation Patient Navigator each year

Tiles w/ Featured Tile

"Going forward, don’t think that the only measure of success is a cure for cancer. This type of research will make treatments easier for people like me and improve our chance of success. That’s all I can ask for." - Colin Hackett, seven-time Ironman triathlete, diagnosed with advanced colorectal cancer at age 34

Calls to Action

This content block type can be used to display call to action links to engage site visitors to complete tasks or drive them to other pages.

Categories

Share:

Keep the perpetual giving spirit going!

Make an Investment Today

Alberta Cancer Foundation launches Giving Tuesday campaign to ‘create more moments,’ featuring 30-year-old patient Jordan Turko

Tuesday, November 29, 2022

All donations made to the Alberta Cancer Foundation’s campaign will be matched up to $25,000. November 25, 2022 – Alberta – The Alberta Cancer Foundation (ACF) is honoured to announce their Giving Tuesday campaign featuring the powerful story of Jordan Turko—an otherwise healthy 30-year-old who recently received a diagnosis of stage four lung cancer. All … Read More


Read More

Recognizing 10 years of philanthropic support for prostate cancer research

Wednesday, October 12, 2022

Recognizing 10 years of philanthropic support for prostate cancer research October 12, 2022 – Edmonton, AB – Two powerhouse researchers in prostate cancer will change the way we treat the disease, thanks to funding from legendary volunteer fundraisers, the Bird Dogs and the Alberta Cancer Foundation. Working with the Alberta Cancer Foundation and the University … Read More


Read More

Enbridge Tour Alberta for Cancer announces $3.6M, and counting, in support of the Alberta Cancer Foundation

Saturday, July 23, 2022

After two years, the annual Enbridge Tour Alberta for Cancer, Alberta’s largest cycling fundraiser, shifts back to an in person event, supporting breakthrough cancer research and care at the 17 cancer centres across Alberta. July 23, 2022 – Alberta – After two years of cancelled events and virtual rides, the Enbridge Tour Alberta for Cancer … Read More


Read More

CAR T-cell therapy showing positive patient outcomes

Tuesday, July 5, 2022

EDMONTON – Clinical trials for “Made-in-Alberta” Chimeric Antigen Receptor (CAR) T-cell therapy are showing very promising results for some patients where chemotherapy and radiation have stopped working. Last fall, Don Goss suffered a relapse seven weeks after finishing two years of traditional chemotherapy for acute lymphoblastic leukemia. At the time, he made the difficult decision … Read More


Read More